1.
|
Phase: Phase I Type: Treatment Status: Completed Age: Over 18 Sponsor: Pharmaceutical / Industry Protocol IDs: B1311001, SNX-5422-CLN1-001, NCT00506805
|
|
2.
|
Phase: Phase I Type: Treatment Status: Completed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: B1311002, SNX-5422-CLN1-002, NCT00595686
|
|
3.
|
Phase: Phase I Type: Biomarker/Laboratory analysis, Treatment Status: Closed Age: 18 and over Sponsor: NCI Protocol IDs: NCI-08-C-0091, 08-C-0091, NCI-P07318, NCT00644072
|
|
4.
|
Phase: Phase I Type: Biomarker/Laboratory analysis, Treatment Status: Completed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: SNX-5422-CLN1-004, NCT01611623
|